2024 Q2 Form 10-Q Financial Statement

#000149315224019962 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $10.53M $9.225M
YoY Change 1.91% -6.32%
Cost Of Revenue $6.590M $6.405M
YoY Change -9.64% -5.29%
Gross Profit $3.939M $2.820M
YoY Change 29.62% -8.58%
Gross Profit Margin 37.41% 30.57%
Selling, General & Admin $1.858M $1.930M
YoY Change 0.85% 10.65%
% of Gross Profit 47.17% 68.41%
Research & Development $62.47K $126.7K
YoY Change 294.58% 489.03%
% of Gross Profit 1.59% 4.49%
Depreciation & Amortization $516.9K $382.7K
YoY Change 26.44% 26.37%
% of Gross Profit 13.12% 13.57%
Operating Expenses $2.125M $2.230M
YoY Change 6.93% 17.19%
Operating Profit $1.814M $590.6K
YoY Change 72.54% -50.05%
Interest Expense -$27.91K $175.3K
YoY Change -124.16% 29.95%
% of Operating Profit -1.54% 29.68%
Other Income/Expense, Net
YoY Change
Pretax Income $1.991M $780.4K
YoY Change 47.56% -38.27%
Income Tax $558.3K $264.2K
% Of Pretax Income 28.04% 33.85%
Net Earnings $1.290M $457.2K
YoY Change 59.26% -48.3%
Net Earnings / Revenue 12.25% 4.96%
Basic Earnings Per Share $0.10 $0.04
Diluted Earnings Per Share $0.10 $0.04
COMMON SHARES
Basic Shares Outstanding 12.45M shares 12.45M shares
Diluted Shares Outstanding 12.48M shares 12.45M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.844M $5.303M
YoY Change -7.69% -4.11%
Cash & Equivalents $6.844M $8.327M
Short-Term Investments
Other Short-Term Assets $2.952M $3.765M
YoY Change 57.1% 182.72%
Inventory $10.33M $10.46M
Prepaid Expenses $586.5K $741.5K
Receivables $8.793M $12.99M
Other Receivables $0.00 $0.00
Total Short-Term Assets $28.92M $32.52M
YoY Change 3.13% 1.39%
LONG-TERM ASSETS
Property, Plant & Equipment $13.98M $13.27M
YoY Change 9.01% 37.92%
Goodwill $2.534M $2.534M
YoY Change 0.0% 0.0%
Intangibles $2.200M $2.240M
YoY Change -6.78% -6.67%
Long-Term Investments $5.905M $5.889M
YoY Change -5.61% 6.52%
Other Assets $284.8K $284.8K
YoY Change 3.83% 3.83%
Total Long-Term Assets $27.42M $25.06M
YoY Change 10.76% 20.1%
TOTAL ASSETS
Total Short-Term Assets $28.92M $32.52M
Total Long-Term Assets $27.42M $25.06M
Total Assets $56.34M $57.58M
YoY Change 6.71% 8.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.489M $1.398M
YoY Change -8.86% -5.11%
Accrued Expenses $1.259M $699.0K
YoY Change 71.33% 285.28%
Deferred Revenue
YoY Change
Short-Term Debt $619.8K $3.260M
YoY Change -11.02%
Long-Term Debt Due $2.164M $1.665M
YoY Change 192.81% 131.44%
Total Short-Term Liabilities $10.92M $11.90M
YoY Change 34.91% 9.71%
LONG-TERM LIABILITIES
Long-Term Debt $6.103M $6.321M
YoY Change -16.43% 20.25%
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $6.103M $6.321M
YoY Change -16.43% 20.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.92M $11.90M
Total Long-Term Liabilities $6.103M $6.321M
Total Liabilities $17.28M $18.48M
YoY Change 8.15% 10.67%
SHAREHOLDERS EQUITY
Retained Earnings $18.55M $18.51M
YoY Change 9.27% 10.26%
Common Stock $12.45K $12.45K
YoY Change 0.12% 0.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $36.16M $35.97M
YoY Change
Total Liabilities & Shareholders Equity $56.34M $57.58M
YoY Change 6.71% 8.76%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $1.290M $457.2K
YoY Change 59.26% -48.3%
Depreciation, Depletion And Amortization $516.9K $382.7K
YoY Change 26.44% 26.37%
Cash From Operating Activities $7.596M -$532.3K
YoY Change -6.85% 133.21%
INVESTING ACTIVITIES
Capital Expenditures $1.186M $478.1K
YoY Change -69.85% 124.41%
Acquisitions
YoY Change
Other Investing Activities -$1.581M $305.2K
YoY Change -2273.62% -189.05%
Cash From Investing Activities -$2.767M -$172.9K
YoY Change -28.32% -68.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $185.9K
YoY Change 4.66%
Cash From Financing Activities -3.982M $1.297M
YoY Change 51.51% 94.61%
NET CHANGE
Cash From Operating Activities 7.596M -$532.3K
Cash From Investing Activities -2.767M -$172.9K
Cash From Financing Activities -3.982M $1.297M
Net Change In Cash 847.6K $618.9K
YoY Change -49.16% -317.21%
FREE CASH FLOW
Cash From Operating Activities $7.596M -$532.3K
Capital Expenditures $1.186M $478.1K
Free Cash Flow $6.410M -$1.010M
YoY Change 51.82% 128.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A0
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2024Q1 FSI Commissions
Commissions
usd
CY2023Q1 FSI Lease Termination Fee
LeaseTerminationFee
usd
CY2023Q1 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
usd
CY2024Q1 us-gaap Investments
Investments
usd
CY2023Q4 us-gaap Investments
Investments
usd
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-31540
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
FLEXIBLE SOLUTIONS INTERNATIONAL INC.
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
71-1630889
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
6001 54 Ave.
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Taber
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AB
CY2024Q1 dei Entity Address Country
EntityAddressCountry
CA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
T1G 1X4
CY2024Q1 dei City Area Code
CityAreaCode
(403)
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
223-2995
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2024Q1 dei Trading Symbol
TradingSymbol
FSI
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12450532 shares
CY2024Q1 us-gaap Cash
Cash
5302954 usd
CY2023Q4 us-gaap Cash
Cash
5017583 usd
CY2024Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
3023757 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
2690241 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12992543 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9843056 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
10459256 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
11134889 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
741495 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1540923 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
32520005 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
30226692 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13267240 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13171787 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
115293 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2240000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2280000 usd
CY2024Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
840592 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
824254 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
5889161 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
6033960 usd
CY2024Q1 us-gaap Goodwill
Goodwill
2534275 usd
CY2023Q4 us-gaap Goodwill
Goodwill
2534275 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
284794 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
284794 usd
CY2024Q1 us-gaap Assets
Assets
57576067 usd
CY2023Q4 us-gaap Assets
Assets
55471055 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1397915 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1984592 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
699005 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
284131 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
131827 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
148292 usd
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
4749391 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4485213 usd
CY2024Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3259935 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1810479 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
59520 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1665440 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1281632 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
11903513 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10053859 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
55773 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
260047 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
260047 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6321396 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6833304 usd
CY2024Q1 us-gaap Liabilities
Liabilities
18484956 usd
CY2023Q4 us-gaap Liabilities
Liabilities
17202983 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12450532 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12450532 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12432523 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12432523 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
12451 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
12436 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
12451 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
12436 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18211607 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17932015 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-767923 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-795146 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
18510277 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
18053051 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
35966412 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
35202356 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
3124699 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
3065716 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39091111 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
38268072 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57576067 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55471055 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9224872 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9847517 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6404505 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6762525 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
2820367 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
3084992 usd
CY2024Q1 us-gaap Salaries And Wages
SalariesAndWages
651158 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
671692 usd
CY2024Q1 us-gaap Officers Compensation
OfficersCompensation
417859 usd
CY2023Q1 us-gaap Officers Compensation
OfficersCompensation
393014 usd
CY2024Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
244260 usd
CY2023Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
201530 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
175266 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
134870 usd
CY2024Q1 us-gaap Other General Expense
OtherGeneralExpense
157623 usd
CY2023Q1 us-gaap Other General Expense
OtherGeneralExpense
98846 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
126654 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21502 usd
CY2024Q1 FSI Consulting
Consulting
99921 usd
CY2023Q1 FSI Consulting
Consulting
62977 usd
CY2024Q1 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
73676 usd
CY2023Q1 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
7487 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
66949 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
48398 usd
CY2024Q1 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
66261 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
60995 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
62767 usd
CY2024Q1 FSI Investor Relations And Transfer Agent Fee
InvestorRelationsAndTransferAgentFee
39304 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
30150 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
25295 usd
CY2024Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
13532 usd
CY2023Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
12578 usd
CY2024Q1 FSI Shipping Cost
ShippingCost
7829 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1635 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2576 usd
CY2023Q1 FSI Commissions
Commissions
2985 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
2229802 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1902727 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
590565 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1182265 usd
CY2024Q1 FSI Lease Termination Fee
LeaseTerminationFee
41350 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
182975 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
69995 usd
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
48197 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
780387 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
264178 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
516209 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
58983 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
457226 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12449699 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12449699 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
516209 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
27223 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
543432 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
58983 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
484449 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
516209 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
964494 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
253357 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
185298 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
422669 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
342810 usd
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
13694 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
12775 usd
CY2024Q1 FSI Lease Right Of Use Financing
LeaseRightOfUseFinancing
1186 usd
CY2023Q1 FSI Lease Right Of Use Financing
LeaseRightOfUseFinancing
1745 usd
CY2024Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-41350 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
182975 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
69995 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3149487 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1383671 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-675633 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-39607 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-799428 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
21497 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-171028 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-179149 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
264178 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
152577 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-16465 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-273223 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-532251 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-228229 usd
CY2024Q1 FSI Payments To Acquire Long Term Deposits
PaymentsToAcquireLongTermDeposits
21778 usd
CY2023Q1 FSI Payments To Acquire Long Term Deposits
PaymentsToAcquireLongTermDeposits
342747 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
478123 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
213060 usd
CY2024Q1 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
327000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-172901 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-555807 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1449456 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
844913 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
185916 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
177639 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
57816 usd
CY2024Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
50790 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
14520 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
26250 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13600 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1296816 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
666354 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27223 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-167239 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
618887 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-284921 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7707824 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6815099 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8326711 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6530178 usd
CY2024Q1 us-gaap Cash
Cash
5302954 usd
CY2023Q1 us-gaap Cash
Cash
5530178 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
3023757 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
1000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8326711 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6530178 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
38268072 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
27223 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
26250 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
253357 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39091111 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
35238970 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-167239 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
964494 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13600 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
185298 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
36235123 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zwun4of7g4H1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <i><span id="xdx_863_z2kbFklKh1I9">Use of Estimates</span></i>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and would impact the results of operations and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates and underlying assumptions are reviewed at each period end. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant areas requiring the use of management estimates include assumptions and estimates relating to the valuation of goodwill and intangible assets, valuation of assets acquired at fair value, asset impairment analysis, share-based payments, valuation allowances for deferred income tax assets, determination of useful lives of property, equipment and leaseholds and intangible assets, recoverability of accounts receivable, recoverability of investments, discount rates for right of use assets and the costing and recoverable value of inventory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zXevU6ME2ii7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) <i><span id="xdx_86F_zyUg1q2tepSb">Risk Management</span>.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s credit risk is primarily attributable to its accounts receivable. The amounts presented in the accompanying consolidated balance sheets are net of allowances for doubtful accounts, estimated by the Company’s management based on prior experience and the current economic environment. The Company is exposed to credit-related losses in the event of non-payment by customers. Credit exposure is minimized by dealing with only credit worthy counterparties. Revenue for the Company’s three primary customers totaled $<span id="xdx_901_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zXtfA4Ilxdhj" title="Sales">5,106,905</span> (<span id="xdx_90E_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_z6o9MVeAEaAf" title="Accounts receivable, after allowance for credit loss">55</span>%) for the three months ended March 31, 2024 (2023 - $<span id="xdx_90C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zOIpbbAj1jki" title="Sales">4,366,106</span> or <span id="xdx_909_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zwLJYgdweEL3" title="Accounts receivable, after allowance for credit loss">44</span>%). Accounts receivable for the Company’s three primary customers totaled $<span id="xdx_903_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zTIOvE4qRz1i" title="Sale">7,843,766</span> (<span id="xdx_90C_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z9QJ48EzRGSf" title="Accounts receivable, after allowance for credit loss, percentage">60</span>%) at March 31, 2024 (December 31, 2023 - $<span id="xdx_903_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zBsoQR0MHaV2" title="Sale">6,561,164</span> or<span id="xdx_90E_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zC6maiH32m3" title="Accounts receivable, after allowance for credit loss, percentage"> 67</span>%). See Note 4 for allowance for doubtful accounts, all unrelated to our primary customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The credit risk on cash is limited because the Company limits its exposure to credit loss by placing its cash with major financial institutions. The Company maintains cash balances at financial institutions which at times exceed federally insured amounts. The Company has not experienced any losses in such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to foreign risk to the extent that market value rate fluctuations materially differ for financial assets and liabilities denominated in foreign currencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to manage its exposure to foreign exchange risks, the Company closely monitors the fluctuations in the foreign currency exchange rates and the impact on the value of cash, accounts receivable, and accounts payable and accrued liabilities. The Company has not hedged its exposure to currency fluctuations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to interest rate risk to the extent that the fair value or future cash flows for financial liabilities will fluctuate as a result of changes in market interest rates. The Company is exposed to interest rate risk on its long-term debt subject to fixed long-term interest rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to manage its exposure to interest rate risk, the Company closely monitors fluctuations in market interest risks and will refinance its long-term debt where possible to obtain more favourable rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.055 pure
CY2024Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
35910 usd
CY2024Q1 us-gaap Security Deposit
SecurityDeposit
5440 usd
CY2024Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-41350 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
167222 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
51929 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
115293 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
13694 usd
CY2024Q1 FSI Operating Lease Right Of Use Asset Early Termination Of Lease
OperatingLeaseRightOfUseAssetEarlyTerminationOfLease
101599 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
167222 usd
CY2023 FSI Lease Interest Expense
LeaseInterestExpense
6151 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
58080 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
115293 usd
CY2024Q1 FSI Lease Interest Expense
LeaseInterestExpense
1186 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
14880 usd
CY2024Q1 FSI Operating Lease Liability Early Termination Of Lease
OperatingLeaseLiabilityEarlyTerminationOfLease
101599 usd
CY2024Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
13281820 usd
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
10133249 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
289277 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
290193 usd
CY2024Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
12992543 usd
CY2023Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
9843056 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2139797 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2682158 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
8319459 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
8452731 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
10459256 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
11134889 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23782060 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10514820 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13267240 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23365705 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10193918 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13171787 usd
CY2024Q1 us-gaap Depreciation
Depreciation
382669 usd
CY2023Q1 us-gaap Depreciation
Depreciation
302810 usd
CY2022Q4 us-gaap Goodwill
Goodwill
2534275 usd
CY2023Q4 us-gaap Goodwill
Goodwill
2534275 usd
CY2024Q1 us-gaap Goodwill
Goodwill
2534275 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
770000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
770000 usd
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
770000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
40000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
40000 usd
CY2024Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
840592 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
824254 usd
CY2024Q1 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
506659 usd
CY2024Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
7330 usd
CY2024Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings
3750000 usd
CY2024Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Land
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
150000 usd
CY2024Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
174582 usd
CY2024Q1 FSI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Long Term Debt
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt
-2849500 usd
CY2024Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
883248 usd
CY2024Q1 FSI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Less Purchase Price
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLessPurchasePrice
376589 usd
CY2024Q1 FSI Investment Eliminated Upon Consolidation
InvestmentEliminatedUponConsolidation
-41538 usd
CY2024Q1 FSI Gain On Acquisition Of Subsidiary
GainOnAcquisitionOfSubsidiary
335051 usd
CY2021 FSI Debt Instrument Maturity Month Year
DebtInstrumentMaturityMonthYear
2023-12
CY2023Q4 us-gaap Investments
Investments
200000 usd
CY2024Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
3319582 usd
CY2023Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
3447125 usd
CY2024Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
1014988 usd
CY2023Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
965052 usd
CY2024Q1 FSI Realized Investment Gains Losses Net
RealizedInvestmentGainsLossesNet
364403 usd
CY2023Q1 FSI Realized Investment Gains Losses Net
RealizedInvestmentGainsLossesNet
139990 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
8114936 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
6154077 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
8114936 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
6154077 usd
CY2024Q1 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
57816 usd
CY2023 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
2686682 usd
CY2024Q1 us-gaap Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
185916 usd
CY2023 us-gaap Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
725823 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
7986836 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
8114936 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
7986836 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
8114936 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1665440 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1281632 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6321396 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6833304 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
1 pure
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1686000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.26
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
564000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.55
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
8000 shares
CY2023 FSI Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Excercised Options Exercise Price
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExcercisedOptionsExercisePrice
1.70
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.70
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1114000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.13
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
950000 shares
CY2024Q1 FSI Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Granted Options Exercise Price
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsExercisePrice
2.00
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.00
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
103000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.06
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
15000 shares
CY2024Q1 FSI Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Excercised Options Exercise Price
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExcercisedOptionsExercisePrice
1.75
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.75
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1946000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.65
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
814000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.86
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
822813 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
CY2023Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1272 shares
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
4070 usd
CY2023Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.05
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segments
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9224872 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9847517 usd
CY2024Q1 us-gaap Noncurrent Assets
NoncurrentAssets
18041515 usd
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
18101355 usd

Files In Submission

Name View Source Status
form10-q_htm.xml Edgar Link completed
0001493152-24-019962-index-headers.html Edgar Link pending
0001493152-24-019962-index.html Edgar Link pending
0001493152-24-019962.txt Edgar Link pending
0001493152-24-019962-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
fsi-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
fsi-20240331_cal.xml Edgar Link unprocessable
fsi-20240331_def.xml Edgar Link unprocessable
fsi-20240331_lab.xml Edgar Link unprocessable
fsi-20240331_pre.xml Edgar Link unprocessable